Victoria Hinder

1.2k total citations
18 papers, 264 citations indexed

About

Victoria Hinder is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Victoria Hinder has authored 18 papers receiving a total of 264 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 4 papers in Surgery. Recurrent topics in Victoria Hinder's work include Colorectal Cancer Treatments and Studies (6 papers), Colorectal Cancer Screening and Detection (4 papers) and Prostate Cancer Diagnosis and Treatment (4 papers). Victoria Hinder is often cited by papers focused on Colorectal Cancer Treatments and Studies (6 papers), Colorectal Cancer Screening and Detection (4 papers) and Prostate Cancer Diagnosis and Treatment (4 papers). Victoria Hinder collaborates with scholars based in New Zealand, Canada and United Kingdom. Victoria Hinder's co-authors include Katrina Sharples, Michael Findlay, Peter Gilling, Andrew Kennedy‐Smith, Justin Harvey, Han‐Seung Yoon, Parry Guilford, P.J. O’Sullivan, Mark E. Dalphin and Lisa Cambridge and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Victoria Hinder

17 papers receiving 258 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Victoria Hinder New Zealand 7 136 109 67 64 42 18 264
Amy Gursky United States 5 67 0.5× 82 0.8× 71 1.1× 53 0.8× 26 0.6× 5 208
Nick van Dijk Netherlands 8 151 1.1× 180 1.7× 52 0.8× 72 1.1× 65 1.5× 16 273
Aleksander Ślusarczyk Poland 9 111 0.8× 85 0.8× 37 0.6× 36 0.6× 29 0.7× 33 210
Nayneeta Deshmukh United Kingdom 8 129 0.9× 93 0.9× 94 1.4× 133 2.1× 57 1.4× 13 319
David Morris United States 8 65 0.5× 68 0.6× 64 1.0× 102 1.6× 13 0.3× 25 224
Viktoria Stühler Germany 12 71 0.5× 96 0.9× 139 2.1× 157 2.5× 28 0.7× 34 308
Carmen Mir Spain 7 121 0.9× 70 0.6× 93 1.4× 107 1.7× 23 0.5× 13 264
Natalie Q. Wang Canada 2 79 0.6× 53 0.5× 24 0.4× 111 1.7× 15 0.4× 2 172
Anishka D'souza United States 6 57 0.4× 87 0.8× 66 1.0× 95 1.5× 11 0.3× 25 201
Juan Francisco Rodríguez-Moreno Spain 9 59 0.4× 86 0.8× 74 1.1× 71 1.1× 20 0.5× 37 192

Countries citing papers authored by Victoria Hinder

Since Specialization
Citations

This map shows the geographic impact of Victoria Hinder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Victoria Hinder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Victoria Hinder more than expected).

Fields of papers citing papers by Victoria Hinder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Victoria Hinder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Victoria Hinder. The network helps show where Victoria Hinder may publish in the future.

Co-authorship network of co-authors of Victoria Hinder

This figure shows the co-authorship network connecting the top 25 collaborators of Victoria Hinder. A scholar is included among the top collaborators of Victoria Hinder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Victoria Hinder. Victoria Hinder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Brand, Douglas, Victoria Hinder, Asadullah Khan, et al.. (2025). Exploring Factors Associated with Late Urinary Toxicity After Prostate Stereotactic Body Radiotherapy: Findings from the PACE-B Study. European Urology. 89(1). 71–79.
2.
Brand, Douglas, et al.. (2025). 2750 Exploring predictive factors for late urinary toxicity after prostate SBRT: Findings from the PACE-B Study. Radiotherapy and Oncology. 206. S2009–S2009. 2 indexed citations
3.
Khan, Asadullah, Victoria Hinder, Douglas Brand, et al.. (2025). Dosimetric Comparison of CyberKnife and Conventional Linac Prostate Stereotactic Body Radiation Therapy Plans: Analysis of the PACE-B Study. International Journal of Radiation Oncology*Biology*Physics. 3 indexed citations
4.
Hinder, Victoria, Douglas Brand, John Staffurth, et al.. (2023). The Association between Acute and Late Genitourinary and Gastrointestinal Toxicities: An Analysis of the PACE B Study. Cancers. 15(4). 1288–1288. 10 indexed citations
5.
6.
Gasser, Olivier, Katrina Sharples, Catherine Barrow, et al.. (2017). A phase I vaccination study with dendritic cells loaded with NY-ESO-1 and α-galactosylceramide: induction of polyfunctional T cells in high-risk melanoma patients. Cancer Immunology Immunotherapy. 67(2). 285–298. 44 indexed citations
7.
Hinder, Victoria, Diana Sarfati, Sarah Derrett, et al.. (2016). Methods of a national colorectal cancer cohort study: the PIPER Project.. PubMed. 129(1440). 25–36. 2 indexed citations
8.
Pérez, David, Katrina Sharples, Reuben Broom, et al.. (2015). A randomised phase IIb trial to assess the efficacy of ReCharge ice cream in preventing chemotherapy-induced diarrhoea. Supportive Care in Cancer. 23(11). 3307–3315. 8 indexed citations
9.
Lawrence, Nicola Jane, et al.. (2015). Transient elevation in serum carcinoembryonic antigen while on adjuvant chemotherapy for colon cancer: Is this of prognostic importance?. Asia-Pacific Journal of Clinical Oncology. 13(2). e124–e131. 4 indexed citations
10.
Jackson, Christopher, Katrina Sharples, Mark Jeffery, et al.. (2015). Geographical isolation and uptake of adjuvant chemotherapy for stage III colon cancer: Results from the New Zealand PIPER Cohort study.. Journal of Clinical Oncology. 33(15_suppl). e17504–e17504. 1 indexed citations
11.
Mitchell, Nicola J., et al.. (2014). Transient increase in serum CEA while on adjuvant chemotherapy for colon cancer: Is this of prognostic importance?. Journal of Clinical Oncology. 32(3_suppl). 654–654. 1 indexed citations
12.
Jackson, Christopher, Katrina Sharples, Paul Thompson, et al.. (2014). Dose-intense capecitabine, oxaliplatin and bevacizumab as first line treatment for metastatic, unresectable colorectal cancer: a multi-centre phase II study. BMC Cancer. 14(1). 737–737. 3 indexed citations
13.
Broom, Reuben, Victoria Hinder, Katrina Sharples, et al.. (2014). Everolimus and Zoledronic Acid in Patients With Renal Cell Carcinoma With Bone Metastases: A Randomized First-Line Phase II Trial. Clinical Genitourinary Cancer. 13(1). 50–58. 34 indexed citations
14.
Harvey, V.J., Katrina Sharples, R. Isaacs, et al.. (2013). A randomized phase II study comparing capecitabine alone with capecitabine and oral cyclophosphamide in patients with advanced breast cancer-cyclox II. Annals of Oncology. 24(7). 1828–1834. 5 indexed citations
15.
Frizelle, Frank, et al.. (2013). Colorectal adenocarcinoma cancer in New Zealand in those under 25 years of age (1997–2007). ANZ Journal of Surgery. 84(5). 371–375. 8 indexed citations
16.
O’Sullivan, P.J., Katrina Sharples, Mark E. Dalphin, et al.. (2012). A Multigene Urine Test for the Detection and Stratification of Bladder Cancer in Patients Presenting with Hematuria. The Journal of Urology. 188(3). 741–747. 126 indexed citations
17.
Brown, Julie, Victoria Hinder, Arend E. H. Merrie, et al.. (2011). The colorectal cancer patients' journey: the Auckland region.. PubMed. 124(1331). 18–28. 6 indexed citations
18.
Hinder, Victoria, et al.. (2009). The effects of sorafenib and sunitinib on bone turnover markers in patients with bone metastases from renal cell carcinoma. Journal of Clinical Oncology. 27(15_suppl). e16145–e16145. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amy Gursky Breakdown of academic impact, for papers by Nick van Dijk Breakdown of academic impact, for papers by Aleksander Ślusarczyk Breakdown of academic impact, for papers by Nayneeta Deshmukh Breakdown of academic impact, for papers by David Morris Breakdown of academic impact, for papers by Viktoria Stühler Breakdown of academic impact, for papers by Carmen Mir Breakdown of academic impact, for papers by Natalie Q. Wang Breakdown of academic impact, for papers by Anishka D'souza Breakdown of academic impact, for papers by Juan Francisco Rodríguez-Moreno
Rankless by CCL
2026